KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 97 filers reported holding KURA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $471,000 | +91.5% | 47,363 | +164.3% | 0.25% | +762.1% |
Q4 2019 | $246,000 | -46.6% | 17,922 | -41.0% | 0.03% | -50.8% |
Q3 2019 | $461,000 | -22.9% | 30,400 | 0.0% | 0.06% | +43.9% |
Q2 2019 | $598,000 | -44.3% | 30,400 | -53.0% | 0.04% | -18.0% |
Q1 2019 | $1,073,000 | +276.5% | 64,700 | +296.9% | 0.05% | +212.5% |
Q3 2018 | $285,000 | +26.7% | 16,300 | +31.5% | 0.02% | +23.1% |
Q2 2018 | $225,000 | -81.2% | 12,400 | -80.6% | 0.01% | -82.9% |
Q1 2018 | $1,196,000 | – | 63,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |